Back to Journals » Therapeutics and Clinical Risk Management » Volume 21

ISSN: 1178-203X


Archive: Volume 21, 2025

Airway Organoid Models as Pivotal Tools for Unraveling Molecular Mechanisms and Therapeutic Targets in Respiratory Diseases: A Literature Review

Jiang SP, Lin BQ, Zhou XQ, Li MH, Feng ZC, Qin YY, Lin SQ, Zhou ZQ, Peng Y, Li L

Therapeutics and Clinical Risk Management 2025, 21:975-986

Published Date: 24 June 2025

The Application of Opacification-Development Ratio Based on CT Scan for Diagnosing Pediatric Chronic Rhinosinusitis

Zhang J, Yang A, Chen T, Cao Y, Lv Q, Xu Y, Liao Z, Chen X, Ye Z, Lai R, Hong H

Therapeutics and Clinical Risk Management 2025, 21:895-904

Published Date: 13 June 2025

Muscular and Renal Safety of Ticagrelor with High-Intensity Statins: Retrospective Cohort Findings

Alshammari AS, Shalwala AA, Alnuhait MA, Alhazmi AY, Fagieha RE, Hallabi NB, Alandijani EA, Aloufi MA, Alharbi MS, Alzahrani RS, Elkholy EM, Elrggal ME, Alotaibi AS

Therapeutics and Clinical Risk Management 2025, 21:861-867

Published Date: 8 June 2025

Effect of Low-Dose Esketamine Combined with Propofol on Postoperative Fatigue in Colonoscopy: A Randomized Clinical Trial

Sun X, Du Q, Liang Y, Tang L, Wei Q, Guo P, Liu X

Therapeutics and Clinical Risk Management 2025, 21:807-816

Published Date: 29 May 2025

Long-Term Benefits of N-Butylphthalide in Preventing Ischemic Stroke Recurrence: A 12-Month Prospective Study

Liu W, Shao Y, Liu J, Hao J, Lu Y, Yang L, Wang J, Ning X

Therapeutics and Clinical Risk Management 2025, 21:781-792

Published Date: 27 May 2025

Cerebrovascular Autoregulation-Based Optimal Mean Arterial Pressure During Prostate Surgery – A Secondary Analysis of a Prospective Cohort Study

Mewes C, Wei P, Yang Y, Kainz E, Kahl U, Beck S, Graefen M, Zöllner C, Fischer M

Therapeutics and Clinical Risk Management 2025, 21:757-767

Published Date: 27 May 2025

Relationship Between Timing of PCSK9 Inhibitor Monoclonal Antibody Initiation and Clinical Outcomes in Patients with Prior Cardiovascular Events

Sidelnikov E, Kalich BA, Miglins ML, Multani JK, Tuly R, Hawkins K, Baber U

Therapeutics and Clinical Risk Management 2025, 21:727-736

Published Date: 21 May 2025

Elevated MPV: A Key Indicator of Acute Anterior Circulation Stroke Prognosis in Mechanical Thrombectomy

Tian SY, Yu MJ, Mei K, Xu B, Xiao LC, Wen HB, Shang FR

Therapeutics and Clinical Risk Management 2025, 21:715-725

Published Date: 19 May 2025

Corticosteroid Therapy for Diffuse Alveolar Hemorrhage with Respiratory Failure in Hematologic Malignancies: A Retrospective Cohort Study

Ahn JH, Song KM, Huh JW, Lee JH, Hong SB, Lee JH, Lim CM, Lee KH, Koh Y

Therapeutics and Clinical Risk Management 2025, 21:705-714

Published Date: 17 May 2025

Lessons Learned From Awake ECMO Approach in Covid-19-Related Acute Respiratory Distress Syndrome - a Scoping Review

Sklienka P, Burša F, Frelich M, Máca J, Romanová T, Vodička V, Straková H, Bílená M, Jor O, Neiser J, Tomášková H

Therapeutics and Clinical Risk Management 2025, 21:655-668

Published Date: 13 May 2025

Improved Tubeless Airway Management in JORRP Surgery: Comparative Analysis of Pre- and Post-THRIVE Implementation

Lei G, Yang S, Wu L, Yin Y, Xi C, Xiao Y, Wang G

Therapeutics and Clinical Risk Management 2025, 21:647-654

Published Date: 8 May 2025

Impact of Relaxation and Music Intervention on Psychological and Gastrointestinal Health in Military Recruits: A Prospective Study

Liu J, Liu T, Lu H, Zhao X, Ma S, Song F, Qiao N, Cheng W, Qi X

Therapeutics and Clinical Risk Management 2025, 21:593-608

Published Date: 2 May 2025

Higher Neutrophil-Percentage-to-Albumin Ratio Was Associated with Poor Outcome in Endovascular Thrombectomy Patients

Xu M, Zhai Q, Wei B, Chen S, E Y, Huang Z, Qi J, Xu Y

Therapeutics and Clinical Risk Management 2025, 21:565-573

Published Date: 26 April 2025

Feasibility and Outcomes of Vessel-Sparing Surgery for Soft Tissue Sarcoma of the Thigh Adjacent to Femoral Vessels

Yang ZM, Qu H, Wang KY, Wu JD, Liu B, Jin LB, Huang X, Lin N, Tao HM, Ye ZM

Therapeutics and Clinical Risk Management 2025, 21:553-564

Published Date: 25 April 2025

Advanced Therapies in Elderly Patients With Inflammatory Bowel Disease: A Comparative Retrospective Cohort Study in Taiwan

Lin SH, Chiu HY, Kuo CJ, Chen CM, Su MY, Wu RC, Chiu CT, Chang CW, Chung CS, Pan YB, Le PH

Therapeutics and Clinical Risk Management 2025, 21:533-542

Published Date: 25 April 2025

Posterior Pericardial Window and a Single Pleural Drain: A Dual Defence Against Post-CABG Pericardial Effusion and Atrial Fibrillation

Ranjan R, Kapetanakis S, Chandrasekaran V, Kaba RA, Momin AU

Therapeutics and Clinical Risk Management 2025, 21:481-487

Published Date: 15 April 2025

Association of Prognostic Nutritional Index with Post-Discharge Bleeding After Percutaneous Coronary Intervention in ACS Patients on DAPT

Elkenany NM, Sabah ZU, Agiba NA, Elmahdy HK, Elsherbiny EAY, Said SRA, Nassef EM, Alhawy AME, Ahmed MSM, Elsharkawy AMS, Hussein AMM, Elmalah AA

Therapeutics and Clinical Risk Management 2025, 21:455-466

Published Date: 10 April 2025

Recurrent Rhegmatogenous Retinal Detachment: Characteristics, Risk Factors, and Outcomes

Aleshawi A, Al-Dwairi R, Saleh OA, Adi S, Al Beiruti S, Alasheh A, Alsaadi MA, Ouda ZH, Allouh MZ

Therapeutics and Clinical Risk Management 2025, 21:425-440

Published Date: 1 April 2025

A Novel Three-Step Technique for the Simple, Safe, and Efficient Complete Removal of Idiopathic Epiretinal Membrane

Wei Q, Cai C, Yi L, Li M, Zhang W, Chen J, Qiu Q

Therapeutics and Clinical Risk Management 2025, 21:407-413

Published Date: 24 March 2025

Serum RIPK1, Acute Lung Injury, and Outcomes in Severe Traumatic Brain Injury: A Multicenter Prospective Study

Cai L, Dou X, Dong W, Zou K, Zhang L, Hong H, Zhang X, Liu J, Tian D, Wu X, Zhang J

Therapeutics and Clinical Risk Management 2025, 21:385-405

Published Date: 20 March 2025

Therapeutics and Clinical Risk Management - 20th Anniversary

Walsh GM, Wang DY

Therapeutics and Clinical Risk Management 2025, 21:383-384

Published Date: 19 March 2025

Hepatic Safety Considerations in the Use of Ulipristal Acetate for Symptomatic Uterine Fibroids

Semmler A, de Lange ME, Drenth JPH, Vermeer NS, Bet PM, Huirne JAF, Hehenkamp WJK

Therapeutics and Clinical Risk Management 2025, 21:367-382

Published Date: 19 March 2025

Risk of Serious Immune-Related Adverse Events with Various PD1 and PD-L1 Inhibitors: A Single-Institution, Real-Life, Comparative Study

Boucheron T, Chiche L, Penaranda G, Souquet M, Pegliasco H, Deturmeny J, Brunel V, Barrière N, Arbault-Bitton C, Coquet E, Diaz L, Escoda T

Therapeutics and Clinical Risk Management 2025, 21:273-282

Published Date: 5 March 2025

Health and Economic Advantages Associated With the Use of TachoSil: An Update of Systematic Review

Colombo GL, Droghetti A, Di Matteo S, Ottenjann H, Bruno GM

Therapeutics and Clinical Risk Management 2025, 21:257-271

Published Date: 1 March 2025

Nomogram-Based Prediction of 3-Month Unfavorable Outcome and Early Neurological Deterioration After Endovascular Thrombectomy in Acute Ischemic Stroke

Wu Y, Han J, Cheng Y, Wei M, Liu F, Chen C, Tan Y, Ma W, Yu J, Han J, Luo G, Huo K

Therapeutics and Clinical Risk Management 2025, 21:239-256

Published Date: 27 February 2025

Advancing Heart Valve Replacement: Risk Mitigation of Decellularized Pulmonary Valve Preparation for Its Implementation in Public Tissue Banks

Rodríguez Martínez JI, Castells-Sala C, Piteira AR, Montagner G, Trojan D, Martinez-Legazpi P, Acosta Ocampo A, Fernández-Santos ME, Bermejo J, Jashari R, Pérez ML, Agustí E, Tabera J, Vilarrodona A

Therapeutics and Clinical Risk Management 2025, 21:209-228

Published Date: 26 February 2025

Outperforming Traditional Staging: A Novel Nomogram for HR-Positive Breast Cancer

Liu C, Ding J, Xu J, Fang C, Zhang G, Shi C, Qiu F

Therapeutics and Clinical Risk Management 2025, 21:191-208

Published Date: 25 February 2025

The Impact of Early Protein Advancement in Critically Ill Patients with COVID-19: A Multicenter Cardinality Matching Study

Alissa A, Korayem GB, Aljuhani O, AlFaifi M, Alnajjar LI, Souaan NAL, Albassam M, Alrayes A, Albishi S, Alqahtani RA, Alharthi AF, Alkhushaym N, Alhammad MA, Vishwakarma R, Alharbi A, Alsohimi S, Ababtain A, Al-Dorzi HM, Alqahtani R, Almuaither G, Alarifi LA, Almutairi A, Alharbi MB, Alghamdi AA, Alhmoud MF, Al Sulaiman K

Therapeutics and Clinical Risk Management 2025, 21:177-189

Published Date: 21 February 2025

Serum Periostin as a Novel Biomarker for Predicting 30-Day Major Adverse Cardiac Events After Off-Pump Coronary Artery Bypass Grafting

Su Q, Deng Z, Wei X, Li L, Du B, Guo F, Gu Y, Song J, Yao L

Therapeutics and Clinical Risk Management 2025, 21:161-176

Published Date: 18 February 2025

The Development of Publications on Catheter-Related Bladder Discomfort: A Bibliometric Analysis

Jiang W, Chen X, Peng Y, Zhai W, Zhang X, Zhou Y, Zhou R

Therapeutics and Clinical Risk Management 2025, 21:137-147

Published Date: 4 February 2025

Mesalazine-Induced Acute Pancreatitis in Inflammatory Bowel Disease Patients: A Systematic Review

Pan J, Li Z, Ye C, Zhang X, Yang Q, Zhang X, Zhou Y, Zhang J

Therapeutics and Clinical Risk Management 2025, 21:113-123

Published Date: 27 January 2025

Video Laryngoscopy for Endotracheal Intubation: A Consideration for Manual In-Line Stabilization Without Cervical Collar Versus Full Immobilization

Aramvanitch K, Leela-Amornsin S, Tienpratarn W, Nuanprom P, Aussavanodom S, Yuksen C, Boonsri S, Boonjarus N, Sanepim S

Therapeutics and Clinical Risk Management 2025, 21:103-109

Published Date: 25 January 2025

Obstacles to Early Diagnosis of Gaucher Disease

Nishimura S, Ma C, Sidransky E, Ryan E

Therapeutics and Clinical Risk Management 2025, 21:93-101

Published Date: 25 January 2025

Improving Patient Outcomes in mTBI: The Role of Integrated Nursing Interventions in the Emergency Department

Feng T, Zhao P, Wang J, Du X, Ai M, Yang J, Li J

Therapeutics and Clinical Risk Management 2025, 21:69-80

Published Date: 22 January 2025

Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy

Gu W, Tang J, Liu P, Gan J, Lai J, Xu J, Deng J, Liu C, Wang Y, Zhang G, Yu F, Shi C, Fang K, Qiu F

Therapeutics and Clinical Risk Management 2025, 21:35-53

Published Date: 6 January 2025

Thyroid Dysfunction After Intensity-Modulated Radiotherapy and PD⁃1 Inhibitor Treatment for Locally Advanced Nasopharyngeal Carcinoma

Shang K, He Q, Xu X, Luo X, Zhao C, Liu L, Li Z, Li Y, Jin F

Therapeutics and Clinical Risk Management 2025, 21:15-25

Published Date: 6 January 2025

Environmental PM2.5 Exposure: An Ignored Factor Associated with Blood Cadmium Level in Hemodialysis Patients

Hsu CW, Chan MJ, Weng CH, Tsai TY, Yen TH, Huang WH

Therapeutics and Clinical Risk Management 2025, 21:1-13

Published Date: 3 January 2025